Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Scientific Officer sold 2,043 shares at an average $3.69 ($7,546)
  3. 4 Open-market sale Chief Financial Officer sold 2,946 shares at an average $3.69 ($10,885)
  4. 4 Open-market sale Chief Development Officer sold 2,043 shares at an average $3.69 ($7,545)
  5. 4 Open-market sale Chief Manufacturing Officer sold 2,995 shares at an average $3.69 ($11,061)
  6. 4 Open-market sale Chief People Officer sold 2,535 shares at an average $3.70 ($9,367)
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chief Financial Officer sold 2,525 shares at an average $4.31 ($10,886)
  9. 4 Open-market sale Chief Scientific Officer sold 1,751 shares at an average $4.31 ($7,543)
  10. 4 Open-market sale Chief Development Officer sold 1,732 shares at an average $4.30 ($7,455)
  11. 4 Open-market sale Chief Manufacturing Officer sold 2,536 shares at an average $4.31 ($10,928)
  12. 4 Open-market sale Chief People Officer sold 2,175 shares at an average $4.31 ($9,369)
  13. 4 Open-market sale Chief Development Officer sold 844 shares at $4.33 ($3,655)
  14. 4 Open-market sale Chief Manufacturing Officer sold 1,261 shares at $4.33 ($5,461)
  15. 4 Open-market sale Chief Scientific Officer sold 863 shares at $4.33 ($3,738)
  16. 4 Open-market sale Chief Financial Officer sold 1,347 shares at $4.33 ($5,834)
  17. 4 Open-market sale Chief People Officer sold 1,168 shares at $4.33 ($5,059)
  18. 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)
  19. 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)
  20. 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)

Page 11 of 18 · 354 filings